Quick Answer
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported Research And Development Expense of $2.26 million for the year ending 2025.
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. showed a decrease of -5.9% in Research And Development Expense from 2024 to 2025.
- This data is from CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 20, 2026.
- XBRL data for this metric is available from 2015 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $4.4 thousand | Q2 2016: $18.0 thousand | Q3 2016: $45.2 thousand | Q1 2017: $59.8 thousand | Q2 2017: $25.2 thousand | Q3 2017: $87.7 thousand | Q1 2018: $3.2 thousand | Q2 2018: $4.2 thousand | Q3 2018: $2.9 thousand | Q1 2019: $0.00 | Q2 2019: $0.00 | Q3 2019: $0.00 | Q3 2020: $0.00 | Q1 2021: $0.00 | Q2 2021: $0.00 | Q3 2021: $59.2 thousand | Q1 2022: $10.0 thousand | Q2 2022: $659.7 thousand | Q3 2022: $230.9 thousand | Q4 2022: $5.00 million | Q1 2023: $319.0 thousand | Q2 2023: $309.5 thousand | Q3 2023: $992.7 thousand | Q1 2024: $422.4 thousand | Q2 2024: $924.7 thousand | Q3 2024: $581.8 thousand | Q1 2025: $743.3 thousand | Q2 2025: $501.3 thousand | Q3 2025: $465.2 thousand.
- Historical annual values: Fiscal year 2025: $2.26 million | Fiscal year 2024: $2.40 million | Fiscal year 2023: $1.97 million | Fiscal year 2023: $5.00 million | Fiscal year 2022: $6.27 million | Fiscal year 2022: $5.00 million | Fiscal year 2021: $109.2 thousand | Fiscal year 2020: $0.00 | Fiscal year 2019: $0.00 | Fiscal year 2018: $96.6 thousand | Fiscal year 2017: $260.1 thousand | Fiscal year 2016: $85.3 thousand | Fiscal year 2015: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: